Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough

M. Fujimura, A. Tokuda, N. Ohkura (Kanazawa, Japan)

Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control
Session: Cough, airway hyperresponsiveness and asthma control
Session type: E-Communication Session
Number: 235
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Fujimura, A. Tokuda, N. Ohkura (Kanazawa, Japan). Cough sensitivity, airway responsiveness and exhaled nitric oxide (eNO) for predicting the response to bronchodilator therapy (BDT) in patients with chronic non-productive cough. Eur Respir J 2010; 36: Suppl. 54, 235

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predicting performance of cough reflex sensitivity, exhaled nitric oxide (eNO) and bronchial responsiveness for efficacy of bronchodilator therapy on isolated chronic non-productive cough
Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases
Year: 2011

Predictors of efficacy of bronchodilator therapy for chronic non-productive cough: cough reflex sensitivity, exhaled nitric oxide, bronchial responsiveness?
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008


Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough
Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking
Year: 2005


Benefit of inhaled corticosteroids (ICS) in asthmatic patients with bronchial hyperresponsiveness (BHR) to mannitol and low fractional exhaled nitric oxide (FeNO) levels
Source: International Congress 2017 – Monitoring asthma control
Year: 2017

Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA)
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020


The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients
Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum
Year: 2006


The influence of asthma and COPD exacerbation on exhaled mitric oxide (FENO)
Source: Eur Respir J 2004; 24: Suppl. 48, 409s
Year: 2004

Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Usefulness of fractional exhaled nitric oxide (FeNO) for early diagnosis of asthma in patients with nonspecific respiratory symptoms
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009


Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008

Bronchial nitric oxide is related to symptom relief during fluticasone treatment in COPD
Source: Eur Respir J 2010; 35: 72-78
Year: 2010



How do exhaled nitric oxide (eNO) and a bronchial provocation test (BPT) compare in the diagnostic work up of asthmatic symptoms?
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008

Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR)
Source: Eur Respir J 2004; 24: Suppl. 48, 271s
Year: 2004

Effects of exacerbations and seasonality on exhaled nitric oxide in COPD
Source: Eur Respir J 2005; 26: 1009-1015
Year: 2005



Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma
Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement
Year: 2008


The relationship between exhaled breath nitric oxide, induced sputum and airway physiological responses in occupational asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 476s
Year: 2003

Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma
Source: Eur Respir J 2008; 32: 344-349
Year: 2008



Different patterns of exhaled NO response to acute bronchodilation in asthma
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Correlation between exhaled nitric oxide, airway hyper responsiveness and pulmonary function data in patients with suspected asthma
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009


Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children?
Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma
Year: 2003